Mark W. Kroll, Director at HAEMONETICS CORP (HAE), sold 20,000 shares at $71.09 ($1.4M) on 2012-05-04, disclosed to the SEC on 2012-05-08.
Open-market sale of $1.4M HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2022-08-16 | $1.2M | — | Filing → |
| AXON | SELL | 2022-06-09 | $650K | — | Filing → |
| HAE | SELL | 2021-05-28 | $1.3M | — | Filing → |